Growth hormone deficiency secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) Created page with "__NOTOC__ {{Growth hormone deficiency}} {{CMG}}; {{AE}} ==Overview== *There are no established measures for the secondary prevention of [disease name]. OR *Effective measure..." |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
*There are no established measures for the secondary prevention of [disease name]. | *There are no established measures for the secondary prevention of [disease name]. | ||
*Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3]. | *Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3]. | ||
==References== | ==References== | ||
Revision as of 19:14, 18 August 2017
|
Growth hormone deficiency Microchapters |
|
Differentiating Growth hormone deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Growth hormone deficiency secondary prevention On the Web |
|
American Roentgen Ray Society Images of Growth hormone deficiency secondary prevention |
|
Risk calculators and risk factors for Growth hormone deficiency secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
- There are no established measures for the secondary prevention of [disease name].
- Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].